INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trial.

Majoni SW, Nelson J, Germaine D, Hoppo L, Long S, Divakaran S, Turner B, Graham J, Cherian S, Pawar B, Rathnayake G, Heron B, Maple-Brown L, Batey R, Morris P, Davies J, Fernandes DK, Sundaram M, Abeyaratne A, Wong YHS, Lawton PD, Taylor S, Barzi F, Cass A, INFERR study Group

Open source

DOI: 10.1186/s13063-021-05854-w
Published: 2021 Dec 2
Container: Trials
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13063-021-05854-w,
  title = {INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trial.},
  author = {Majoni SW and Nelson J and Germaine D and Hoppo L and Long S and Divakaran S and Turner B and Graham J and Cherian S and Pawar B and Rathnayake G and Heron B and Maple-Brown L and Batey R and Morris P and Davies J and Fernandes DK and Sundaram M and Abeyaratne A and Wong YHS and Lawton PD and Taylor S and Barzi F and Cass A and INFERR study Group},
  year = {2021},
  journal = {Trials},
  doi = {10.1186/s13063-021-05854-w},
  url = {https://doi.org/10.1186/s13063-021-05854-w}
}

RIS

TY  - JOUR
TI  - INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trial.
AU  - Majoni SW
AU  - Nelson J
AU  - Germaine D
AU  - Hoppo L
AU  - Long S
AU  - Divakaran S
AU  - Turner B
AU  - Graham J
AU  - Cherian S
AU  - Pawar B
AU  - Rathnayake G
AU  - Heron B
AU  - Maple-Brown L
AU  - Batey R
AU  - Morris P
AU  - Davies J
AU  - Fernandes DK
AU  - Sundaram M
AU  - Abeyaratne A
AU  - Wong YHS
AU  - Lawton PD
AU  - Taylor S
AU  - Barzi F
AU  - Cass A
AU  - INFERR study Group
PY  - 2021
JO  - Trials
DO  - 10.1186/s13063-021-05854-w
UR  - https://doi.org/10.1186/s13063-021-05854-w
ER  -

APA

SW, M., J, N., D, G., L, H., S, L., S, D., B, T., J, G., S, C., B, P., G, R., B, H., L, M., R, B., P, M., J, D., DK, F., M, S., A, A., YHS, W., PD, L., S, T., F, B., A, C., & Group, I. S. (2021). INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trial.. Trials. https://doi.org/10.1186/s13063-021-05854-w

Source records

pubmed · retrieved 2026-09-25T18:40:06.443Z